ClinConnect ClinConnect Logo
Search / Trial NCT06631313

PureWick™ Adolescent Study

Launched by C. R. BARD · Oct 7, 2024

Trial Information

Current as of May 20, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Healthy Adolescent Male or Female aged 12 through 21 years old
  • 2. Able to independently and voluntarily void urine
  • 3. Ability to speak and understand English.
  • 4. Willing to comply with all study procedures in the protocol.
  • 5. Provision of signed and dated informed consent form.
  • Exclusion Criteria:
  • 1. Has urinary retention
  • 2. Incontinent to feces
  • 3. Has any irritation, wound, open lesion at the device application site.
  • 4. For females: currently menstruating without use of an internal device, e.g. tampon or menstrual cup, during the execution of the study.
  • 5. For females: currently pregnant at time of consenting (self-reported)
  • 6. Currently enrolled in or has previously been enrolled in or has completed nursing or other clinical training and courses.
  • 7. Has ever been employed as a home health aide or homecare provider.
  • 8. Any other condition that, in the opinion of the investigator, would preclude them from participating in the study.

About C. R. Bard

C.R. Bard, a leading global provider of innovative medical technologies, specializes in developing and manufacturing a wide range of products for vascular, urology, and surgical specialties. With a strong commitment to improving patient outcomes, the company focuses on advancing healthcare through research and clinical trials that support the efficacy and safety of its devices. C.R. Bard is dedicated to fostering collaboration with healthcare professionals and regulatory bodies to ensure that its solutions meet the highest standards of quality and effectiveness, ultimately enhancing the quality of life for patients worldwide.

Locations

Fair Lawn, New Jersey, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported